25-Hydroxy Vitamin D EIA, Catalog #AC-57F1. Product Usage: The IDS 25-Hydroxy Vitamin D EIA kit is an enzymeimmunoassay intended for the quantitative determination of 25-hydroxyvitamin D (25-OH D) and other hydroxylated metabolites in human serum or plasma. Results are to be used in conjunction with other clinical and laboratory data to assist the clinician in the assessment of vitamin D sufficiency in adult populations.
Publicado el 23 de enero de 2013 · Inicio del retiro: 7 de noviembre de 2012
Resumen
FDA registra el retiro Z-0697-2013 de dispositivos médicos de Clase II, publicado el 23 de enero de 2013 e iniciado el 7 de noviembre de 2012. Empresa responsable: IDS (Immunodiagnostic Systems Ltd.); Estado: Finalizado; Cantidad reportada: 675 units; Lote: Lot # 17628. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Immunodiagnostic Systems is recalling the 25-Hydroxy Vitamin D EIA, AC-57F1 because the QC report was found to have an erroneous calibrator value assigned. The value of 24.4 ng/mL for calibrator 4 was stated on the QC report, however the correct value should have read 28.4 ng/mL.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- IDS (Immunodiagnostic Systems Ltd.)
- Distribuidor
- US Nationwide Distribution
- Lote
- Lot # 17628
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United Kingdom
Retiros relacionados
- FDALisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count30 de enero de 2013
- FDAPropylthiouracil Tablets, USP, 50 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1480-01) and b)30 de enero de 2013
- FDALisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC30 de enero de 2013
- FDAHoffman LRF Wire Bolt, Catalog number 4933-1-001 through -003.23 de enero de 2013
- FDASpacelabs Smart Disclosure System, Model 92810, is an integrated component of the Intesys Clinical Suite (ICS)23 de enero de 2013
- FDAUltrawave II EX 1320/ Ultrawave III EX 1320 Powered Laser Surgical Instrument. Nd:YAG 1064 nm: Coagulation and23 de enero de 2013
Preguntas sobre este retiro
¿25-Hydroxy Vitamin D EIA, Catalog #AC-57F1. Product Usage: The IDS 25-Hydroxy Vitamin D EIA kit is an enzymeimmunoassay intended for the quantitative determination of 25-hydroxyvitamin D (25-OH D) and other hydroxylated metabolites in human serum or plasma. Results are to be used in conjunction with other clinical and laboratory data to assist the clinician in the assessment of vitamin D sufficiency in adult populations. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0697-2013 el 23 de enero de 2013. Peligro reportado: Immunodiagnostic Systems is recalling the 25-Hydroxy Vitamin D EIA, AC-57F1 because the QC report was found to have an erroneous calibrator value assigned. The value of 24.4 ng/mL for calibrator 4 was stated on the QC report, however the correct value should have read 28.4 ng/mL.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter